A nurse administers a pediatric dose of the Covid-19 vaccine to a girl at a L.A. Care Health Plan vaccination clinic at Los Angeles Mission College in the Sylmar neighborhood in Los Angeles, California, January 19, 2022. (Photo by ROBYN BECK/AFP via Getty Images)
Federal health officials are reviewing a submission from Moderna seeking to have its COVID-19 shots approved for children as young as six months old.
In a series of tweets on July 5, Health Canada said they expect to make a decision by mid-July on whether or not to approve Moderna’s Spikevax COVID-19 vaccine for children between the ages of six months and five years old.
Moderna plans for two COVID shots, each one a quarter of its adult dose, to be given a month apart. If approved by Health Canada, they will be the first pharmaceutical company permitted to provide their vaccine to Canada’s youngest children.
Health Canada also said it received a submission from Pfizer-BioNTech on June 23 requesting authorization of its vaccine for children between six months and four years old.
Meanwhile, federal health minister Jean-Yves Duclos has advised Canadians to get a COVID booster shot every nine months in order for their vaccination status to stay “up-to-date.”
“What exactly do we mean by up-to-date vaccination? Let me be very clear: Up-to-date means you’ve received your last dose in the past nine months,” Duclos said in a June 30 press conference.
“If you’ve already received a first booster, that’s great, and please see if you’re eligible for a second or a third booster to remain up-to-date.”
